Our Team

Espero was founded by a team of experienced pharmaceutical executives.


QUANG PHAM – Founder, Chairman and CEO

Mr. Pham is a pharmaceutical entrepreneur with over 20 years of experience in commercialization and marketing. Prior to founding Espero Pharmaceuticals, Mr. Pham was Founding Partner of D+R LATHIAN, a leading provider of healthcare multichannel marketing solutions to brand teams. He also founded Lathian Systems, an innovative company that provides online data and marketing services to pharmaceutical and biotech companies. As Chairman and CEO, Mr. Pham raised venture capital funding for Lathian, and led its eventual sale to D&R Communications, a pharmaceutical direct marketing company. Additionally, Mr. Pham was President and CEO of Monarch Staffing, a healthcare staffing company in California, and Vice President and General Manager with QTC Management, the largest private provider of government-outsourced disability examinations. Following military service as a U.S. Marine Corps aviator, Mr. Pham began his business career in sales roles with Astra-Merck and Genentech BioOncology. He is a published author and holds a BA in Economics from the University of California, Los Angeles. In 2016, he received the BioFlorida’s Entrepreneur of the Year Award and named a Veteran of Influence by the Jacksonville Business Journal.


JEFF COLE – Co-Founder, President and CFO

Mr. Cole has over 23 years of experience in finance, business development and commercial operations at public and privately held companies. This includes various senior executive roles at companies such as Valeant Pharmaceuticals (NYSE: VRX), Solco Healthcare US, MarcasUSA, and Legacy Pharmaceuticals. His positions at Valeant included CFO North America, and General Manager of the US Specialty Division. During his tenure, Valeant’s revenue in North America increased more than 300%, while later as General Manager, he managed 25 prescription and OTC products across 14 different therapeutic areas. As President of Solco Healthcare US, Mr. Cole launched and managed this generic pharmaceutical subsidiary of Legacy Pharmaceuticals while serving as its CFO. Prior to Espero, Mr. Cole founded J. Scott Capital, a firm that provides capital resources to early stage pharmaceutical companies. He also spent six years at PwC Consulting, and served as a principal in the financial management consulting practice. Mr. Cole is a CPA and received his MBA with honors from the University of Michigan. He holds a BS in Accounting from the University of Southern California.


SEAN PURDY – Vice-President, Commercial Operations

Mr. Purdy has more than 25 years of pharmaceutical commercial operations experience, covering specialties including cardiovascular, pediatrics and women’s health. He has held sales leadership, marketing, and sales operational roles at companies such as Merck & Co, Arbor Pharmaceuticals, Solvay Pharmaceuticals and Shionogi & Co. At both Arbor and Shionogi, Mr. Purdy focused on one of Espero’s key areas, the chronic angina market, promoting Nitrolingual® Pumpspray, Espero’s first commercially marketed product. As National Sales Director at Arbor, he helped lead and build a team of more than 250 sales representatives. Mr. Purdy holds a Bachelor of Science in Business Administration, with a focus on Marketing, from the University of Tennessee, Knoxville.


WAYNE YETTER – Director and Senior Advisor

Mr. Yetter is a pharmaceutical industry veteran, board director and advisor. He has held leadership positions at global companies, including President and CEO of Novartis Pharmaceuticals and founding CEO of Astra-Merck (now AstraZeneca). He has also held senior roles at IMS Health, Odyssey Pharmaceuticals, and Verispan. Mr. Yetter serves as a director of InfuSystem Holdings, with previous board roles that include Chairman of NuPathe, Noven Pharmaceuticals, Transkaryotic Therapies and Lead Independent Director of Matria Healthcare. He was previously a member of the pharmaceutical industry association (PhRMA) Executive Committee. Mr. Yetter holds a B.A. in Biology from Wilkes University and an M.B.A from Bryant University.